134 related articles for article (PubMed ID: 35904671)
1. The German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristics.
Schons M; Pilgram L; Reese JP; Stecher M; Anton G; Appel KS; Bahmer T; Bartschke A; Bellinghausen C; Bernemann I; Brechtel M; Brinkmann F; Brünn C; Dhillon C; Fiessler C; Geisler R; Hamelmann E; Hansch S; Hanses F; Hanß S; Herold S; Heyder R; Hofmann AL; Hopff SM; Horn A; Jakob C; Jiru-Hillmann S; Keil T; Khodamoradi Y; Kohls M; Kraus M; Krefting D; Kunze S; Kurth F; Lieb W; Lippert LJ; Lorbeer R; Lorenz-Depiereux B; Maetzler C; Miljukov O; Nauck M; Pape D; Püntmann V; Reinke L; Römmele C; Rudolph S; Sass J; Schäfer C; Schaller J; Schattschneider M; Scheer C; Scherer M; Schmidt S; Schmidt J; Seibel K; Stahl D; Steinbeis F; Störk S; Tauchert M; Tebbe JJ; Thibeault C; Toepfner N; Ungethüm K; Vadasz I; Valentin H; Wiedmann S; Zoller T; Nagel E; Krawczak M; von Kalle C; Illig T; Schreiber S; Witzenrath M; Heuschmann P; Vehreschild JJ;
Eur J Epidemiol; 2022 Aug; 37(8):849-870. PubMed ID: 35904671
[TBL] [Abstract][Full Text] [Related]
2. Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP).
Horn A; Krist L; Lieb W; Montellano FA; Kohls M; Haas K; Gelbrich G; Bolay-Gehrig SJ; Morbach C; Reese JP; Störk S; Fricke J; Zoller T; Schmidt S; Triller P; Kretzler L; Rönnefarth M; Von Kalle C; Willich SN; Kurth F; Steinbeis F; Witzenrath M; Bahmer T; Hermes A; Krawczak M; Reinke L; Maetzler C; Franzenburg J; Enderle J; Flinspach A; Vehreschild J; Schons M; Illig T; Anton G; Ungethüm K; Finkenberg BC; Gehrig MT; Savaskan N; Heuschmann PU; Keil T; Schreiber S
Infection; 2021 Dec; 49(6):1277-1287. PubMed ID: 34642875
[TBL] [Abstract][Full Text] [Related]
3. Analysis of acute COVID-19 including chronic morbidity: protocol for the deep phenotyping National Pandemic Cohort Network in Germany (NAPKON-HAP).
Steinbeis F; Thibeault C; Steinbrecher S; Ahlgrimm Y; Haack IA; August D; Balzuweit B; Bellinghausen C; Berger S; Chaplinskaya-Sobol I; Cornely O; Doeblin P; Endres M; Fink C; Finke C; Frank S; Hanß S; Hartung T; Hellmuth JC; Herold S; Heuschmann P; Heyckendorf J; Heyder R; Hippenstiel S; Hoffmann W; Kelle SU; Knape P; Koehler P; Kretzler L; Leistner DM; Lienau J; Lorbeer R; Lorenz-Depiereux B; Lüttke CD; Mai K; Merle U; Meyer-Arndt LA; Miljukov O; Muenchhoff M; Müller-Plathe M; Neuhann J; Neuhauser H; Nieters A; Otte C; Pape D; Pinto RM; Pley C; Pudszuhn A; Reuken P; Rieg S; Ritter P; Rohde G; Rönnefarth M; Ruzicka M; Schaller J; Schmidt A; Schmidt S; Schwachmeyer V; Schwanitz G; Seeger W; Stahl D; Stobäus N; Stubbe HC; Suttorp N; Temmesfeld B; Thun S; Triller P; Trinkmann F; Vadasz I; Valentin H; Vehreschild M; von Kalle C; von Lilienfeld-Toal M; Weber J; Welte T; Wildberg C; Wizimirski R; Zvork S; Sander LE; Vehreschild J; Zoller T; Kurth F; Witzenrath M
Infection; 2024 Feb; 52(1):93-104. PubMed ID: 37434025
[TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
5. Definition of the Post-COVID syndrome using a symptom-based Post-COVID score in a prospective, multi-center, cross-sectoral cohort of the German National Pandemic Cohort Network (NAPKON).
Appel KS; Nürnberger C; Bahmer T; Förster C; Polidori MC; Kohls M; Kraus T; Hettich-Damm N; Petersen J; Blaschke S; Bröhl I; Butzmann J; Dashti H; Deckert J; Dreher M; Fiedler K; Finke C; Geisler R; Hanses F; Hopff SM; Jensen BO; Konik M; Lehnert K; de Miranda SMN; Mitrov L; Miljukov O; Reese JP; Rohde G; Scherer M; Tausche K; Tebbe JJ; Vehreschild JJ; Voit F; Wagner P; Weigl M; Lemhöfer C;
Infection; 2024 Apr; ():. PubMed ID: 38587752
[TBL] [Abstract][Full Text] [Related]
6. Severity, predictors and clinical correlates of Post-COVID syndrome (PCS) in Germany: A prospective, multi-centre, population-based cohort study.
Bahmer T; Borzikowsky C; Lieb W; Horn A; Krist L; Fricke J; Scheibenbogen C; Rabe KF; Maetzler W; Maetzler C; Laudien M; Frank D; Ballhausen S; Hermes A; Miljukov O; Haeusler KG; Mokhtari NEE; Witzenrath M; Vehreschild JJ; Krefting D; Pape D; Montellano FA; Kohls M; Morbach C; Störk S; Reese JP; Keil T; Heuschmann P; Krawczak M; Schreiber S;
EClinicalMedicine; 2022 Sep; 51():101549. PubMed ID: 35875815
[TBL] [Abstract][Full Text] [Related]
7. Ethical and coordinative challenges in setting up a national cohort study during the COVID-19 pandemic in Germany.
Tilch K; Hopff SM; Appel K; Kraus M; Lorenz-Depiereux B; Pilgram L; Anton G; Berger S; Geisler R; Haas K; Illig T; Krefting D; Lorbeer R; Mitrov L; Muenchhoff M; Nauck M; Pley C; Reese JP; Rieg S; Scherer M; Stecher M; Stellbrink C; Valentin H; Winter C; Witzenrath M; Vehreschild JJ
BMC Med Ethics; 2023 Oct; 24(1):84. PubMed ID: 37848886
[TBL] [Abstract][Full Text] [Related]
8. Comparison of post-COVID-19 symptoms in patients infected with the SARS-CoV-2 variants delta and omicron-results of the Cross-Sectoral Platform of the German National Pandemic Cohort Network (NAPKON-SUEP).
Hopff SM; Appel KS; Miljukov O; Schneider J; Addo MM; Bals R; Bercker S; Blaschke S; Bröhl I; Büchner N; Dashti H; Erber J; Friedrichs A; Geisler R; Göpel S; Hagen M; Hanses F; Jensen BO; Keul M; Krawczyk A; Lorenz-Depiereux B; Meybohm P; Milovanovic M; Mitrov L; Nürnberger C; Obst W; Römmele C; Schäfer C; Scheer C; Scherer M; Schmidt J; Seibel K; Sikdar S; Tebbe JJ; Tepasse PR; Thelen P; Vehreschild MJGT; Weismantel C; Vehreschild JJ
Infection; 2024 May; ():. PubMed ID: 38700656
[TBL] [Abstract][Full Text] [Related]
9. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A;
JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 infection in the first trimester and the risk of early miscarriage: a UK population-based prospective cohort study of 3041 pregnancies conceived during the pandemic.
Balachandren N; Davies MC; Hall JA; Stephenson JM; David AL; Barrett G; O'Neill HC; Ploubidis GB; Yasmin E; Mavrelos D
Hum Reprod; 2022 May; 37(6):1126-1133. PubMed ID: 35389480
[TBL] [Abstract][Full Text] [Related]
11. Improvements in Patient Monitoring in the Intensive Care Unit: Survey Study.
Poncette AS; Mosch L; Spies C; Schmieding M; Schiefenhövel F; Krampe H; Balzer F
J Med Internet Res; 2020 Jun; 22(6):e19091. PubMed ID: 32459655
[TBL] [Abstract][Full Text] [Related]
12. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana MA; Cargill T; Dhanasekaran R; García-Juárez I; Hagström H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):1008-1016. PubMed ID: 32866433
[TBL] [Abstract][Full Text] [Related]
13. Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial.
Bosteels C; Maes B; Van Damme K; De Leeuw E; Declercq J; Delporte A; Demeyere B; Vermeersch S; Vuylsteke M; Willaert J; Bollé L; Vanbiervliet Y; Decuypere J; Libeer F; Vandecasteele S; Peene I; Lambrecht B
Trials; 2020 Jun; 21(1):491. PubMed ID: 32503663
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study.
Götzinger F; Santiago-García B; Noguera-Julián A; Lanaspa M; Lancella L; Calò Carducci FI; Gabrovska N; Velizarova S; Prunk P; Osterman V; Krivec U; Lo Vecchio A; Shingadia D; Soriano-Arandes A; Melendo S; Lanari M; Pierantoni L; Wagner N; L'Huillier AG; Heininger U; Ritz N; Bandi S; Krajcar N; Roglić S; Santos M; Christiaens C; Creuven M; Buonsenso D; Welch SB; Bogyi M; Brinkmann F; Tebruegge M;
Lancet Child Adolesc Health; 2020 Sep; 4(9):653-661. PubMed ID: 32593339
[TBL] [Abstract][Full Text] [Related]
15. Serial measurements in COVID-19-induced acute respiratory disease to unravel heterogeneity of the disease course: design of the Maastricht Intensive Care COVID cohort (MaastrICCht).
Tas J; van Gassel RJJ; Heines SJH; Mulder MMG; Heijnen NFL; Acampo-de Jong MJ; Bels JLM; Bennis FC; Koelmann M; Groven RVM; Donkers MA; van Rosmalen F; Hermans BJM; Meex SJ; Mingels A; Bekers O; Savelkoul P; Oude Lashof AML; Wildberger J; Tijssen FH; Buhre W; Sels JEM; Ghossein-Doha C; Driessen RGH; Kubben PL; Janssen MLF; Nicolaes GAF; Strauch U; Geyik Z; Delnoij TSR; Walraven KHM; Stehouwer CD; Verbunt JAMCF; Van Mook WNKA; van Santen S; Schnabel RM; Aries MJH; van de Poll MCG; Bergmans D; van der Horst ICC; van Kuijk S; van Bussel BCT
BMJ Open; 2020 Sep; 10(9):e040175. PubMed ID: 32994259
[TBL] [Abstract][Full Text] [Related]
16. National strategy for palliative care of severely ill and dying people and their relatives in pandemics (PallPan) in Germany - study protocol of a mixed-methods project.
Bausewein C; Hodiamont F; Berges N; Ullrich A; Gerlach C; Oechsle K; Pauli B; Weber J; Stiel S; Schneider N; Krumm N; Rolke R; Gebel C; Jansky M; Nauck F; Wedding U; van Oorschot B; Roch C; Werner L; Fischer M; Schallenburger M; Reuters MC; Schwartz J; Neukirchen M; Gülay A; Maus K; Jaspers B; Radbruch L; Heckel M; Klinger I; Ostgathe C; Kriesen U; Junghanß C; Lehmann E; Gesell D; Gauder S; Boehlke C; Becker G; Pralong A; Strupp J; Leisse C; Schloesser K; Voltz R; Jung N; Simon ST;
BMC Palliat Care; 2022 Jan; 21(1):10. PubMed ID: 35027041
[TBL] [Abstract][Full Text] [Related]
17. Sleep quality deterioration in middle-aged and older adults living in a rural Ecuadorian village severely struck by the SARS-CoV-2 pandemic. A population-based longitudinal prospective study.
Del Brutto OH; Mera RM; Costa AF; Recalde BY; Castillo PR
Sleep; 2021 Aug; 44(8):. PubMed ID: 33608714
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
20. Characteristics and outcomes of patients with COVID-19 admitted to hospital and intensive care in the first phase of the pandemic in Canada: a national cohort study.
Murthy S; Archambault PM; Atique A; Carrier FM; Cheng MP; Codan C; Daneman N; Dechert W; Douglas S; Fiest KM; Fowler R; Goco G; Gu Y; Guerguerian AM; Hall R; Hsu JM; Joffe A; Jouvet P; Kelly L; Kho ME; Kruisselbrink RJ; Kumar D; Kutsogiannis DJ; Lamontagne F; Lee TC; Menon K; O'Grady H; O'Hearn K; Ovakim DH; Pharand SG; Pitre T; Reel R; Reeve B; Rewa O; Richardson D; Rishu A; Sandhu G; Sarfo-Mensah S; Shadowitz E; Sligl W; Solomon J; Stelfox HT; Swanson A; Tessier-Grenier H; Tsang JLY; Wood G;
CMAJ Open; 2021; 9(1):E181-E188. PubMed ID: 33688026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
